HMS5552
HMS5552 is a pharmaceutical drug with 11 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
10 of 10 finished
0.0%
0 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
Clinical Trials (11)
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
A Multi-center 12-week Study of HMS5552 in T2DM
Human Mass Balance Study of HMS5552 in Healthy Subjects
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11